KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $406.0 million.

  • Elevance Health's Depreciation & Amortization (CF) rose 201.01% to $406.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 1098.35%. This contributed to the annual value of $1.5 billion for FY2025, which is 1098.35% up from last year.
  • Latest data reveals that Elevance Health reported Depreciation & Amortization (CF) of $406.0 million as of Q4 2025, which was up 201.01% from $387.0 million recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Depreciation & Amortization (CF) registered a high of $473.0 million during Q4 2022, and its lowest value of $282.0 million during Q1 2021.
  • For the 5-year period, Elevance Health's Depreciation & Amortization (CF) averaged around $383.0 million, with its median value being $383.5 million (2025).
  • Per our database at Business Quant, Elevance Health's Depreciation & Amortization (CF) surged by 3138.89% in 2022 and then tumbled by 2835.5% in 2024.
  • Elevance Health's Depreciation & Amortization (CF) (Quarter) stood at $360.0 million in 2021, then skyrocketed by 31.39% to $473.0 million in 2022, then dropped by 10.36% to $424.0 million in 2023, then fell by 6.13% to $398.0 million in 2024, then grew by 2.01% to $406.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $406.0 million in Q4 2025, compared to $387.0 million in Q3 2025 and $380.0 million in Q2 2025.